Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Zaffaroni

Showing results (11-20 of 234) with videos related to

Pageof 24
Sort By:
Current Medicinal Chemistry|February 21, 2017
Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug ResistanceCinzia Lanzi, Nadia Zaffaroni, Giuliana Cassinelli
Cancer Letters|September 27, 2016
The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomasGiuliana Cassinelli, Nadia Zaffaroni, Cinzia Lanzi
Methods in Molecular Biology (Clifton, N.J.)|March 24, 2009
RNA interference-mediated validation of genes involved in telomere maintenance and evasion of apoptosis as cancer therapeutic targetsMarco Folini, Marzia Pennati, Nadia Zaffaroni
Carcinogenesis|March 8, 2007
Targeting survivin in cancer therapy: fulfilled promises and open questionsMarzia Pennati, Marco Folini, Nadia Zaffaroni
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2006
Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAsNadia Zaffaroni, Marzia Pennati, Marco Folini
Discovery Medicine|March 31, 2010
Emerging role of microRNAs in prostate cancer: implications for personalized medicinePaolo Gandellini, Marco Folini, Nadia Zaffaroni
Biochimica Et Biophysica Acta|May 8, 2009
Targeting the telosome: therapeutic implicationsMarco Folini, Paolo Gandellini, Nadia Zaffaroni
Trends in Molecular Medicine|September 1, 2009
Towards the definition of prostate cancer-related microRNAs: where are we now?Paolo Gandellini, Marco Folini, Nadia Zaffaroni
Seminars in Cancer Biology|March 28, 2017
microRNAs as players and signals in the metastatic cascade: Implications for the development of novel anti-metastatic therapiesPaolo Gandellini, Valentina Doldi, Nadia Zaffaroni
Expert Opinion on Therapeutic Targets|March 20, 2008
Targeting survivin in cancer therapyMarzia Pennati, Marco Folini, Nadia Zaffaroni
Pageof 24

Showing results (11-20 of 234) with videos related to

Sort By:
Pageof 24
Current Medicinal Chemistry|February 21, 2017
Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug ResistanceCinzia Lanzi, Nadia Zaffaroni, Giuliana Cassinelli
Cancer Letters|September 27, 2016
The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomasGiuliana Cassinelli, Nadia Zaffaroni, Cinzia Lanzi
Methods in Molecular Biology (Clifton, N.J.)|March 24, 2009
RNA interference-mediated validation of genes involved in telomere maintenance and evasion of apoptosis as cancer therapeutic targetsMarco Folini, Marzia Pennati, Nadia Zaffaroni
Carcinogenesis|March 8, 2007
Targeting survivin in cancer therapy: fulfilled promises and open questionsMarzia Pennati, Marco Folini, Nadia Zaffaroni
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2006
Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAsNadia Zaffaroni, Marzia Pennati, Marco Folini
Discovery Medicine|March 31, 2010
Emerging role of microRNAs in prostate cancer: implications for personalized medicinePaolo Gandellini, Marco Folini, Nadia Zaffaroni
Biochimica Et Biophysica Acta|May 8, 2009
Targeting the telosome: therapeutic implicationsMarco Folini, Paolo Gandellini, Nadia Zaffaroni
Trends in Molecular Medicine|September 1, 2009
Towards the definition of prostate cancer-related microRNAs: where are we now?Paolo Gandellini, Marco Folini, Nadia Zaffaroni
Seminars in Cancer Biology|March 28, 2017
microRNAs as players and signals in the metastatic cascade: Implications for the development of novel anti-metastatic therapiesPaolo Gandellini, Valentina Doldi, Nadia Zaffaroni
Expert Opinion on Therapeutic Targets|March 20, 2008
Targeting survivin in cancer therapyMarzia Pennati, Marco Folini, Nadia Zaffaroni
Pageof 24